secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0000896622-24-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptar Q4 adjusted EPS $1.21 (up 27%), FY 2023 revenue $3.49B, guides Q1 2024 EPS $1.10-$1.18
--------------------------------------------------------------------------------

- Q4 reported sales $838M (+5%), net income $62M (+6%), adjusted EPS $1.21 vs $0.95 (up 27%).
- FY 2023 sales $3.49B (+5%), net income $284M (+19%), adjusted EPS $4.78 vs $3.87 (up 24%).
- Pharma core sales +11% in Q4 driven by proprietary drug delivery systems; Beauty -6%, Closures -4%.
- Q1 2024 adjusted EPS guidance $1.10-$1.18; expects continued Pharma growth and market recovery.
- Dividend $0.41 payable Feb 22; repurchased 81k shares for $10.3M in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000089662224000006/0000896622-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000089662224000006/atr-20240208.htm
  HTML page:      https://secwatch.observer/filing/0000896622-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer